CoChat

Demonstration of safety of probiotics—A review

Open access
Salminen, S · 1998 · International Journal of Food Microbiology

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Abstract

Probiotics are commonly defined as viable microorganisms (bacteria or yeasts) that exhibit a beneficial effect on the health of the host when they are ingested. They are used in foods, especially in fermented dairy products, but also in pharmaceutical preparations. The development of new probiotic strains aims at more active beneficial organisms. In the case of novel microorganisms and modified organisms the question of their safety and the risk to benefit ratio have to be assessed. Lactic acid bacteria (LAB) in foods have a long history of safe use. Members of the genera Lactococcus and Lactobacillus are most commonly given generally-recognised-as-safe (GRAS) status whilst members of the genera Streptococcus and Enterococcus and some other genera of LAB contain some opportunistic pathogens. Lactic acid bacteria are intrinsically resistant to many antibiotics. In many cases resistances are not, however, transmissible, and the species are also sensitive to many clinically used antibiotics even in the case of a lactic acid bacteria- associated opportunistic infection. Therefore no particular safety concern is associated with intrinsic type of resistance. Plasmid-associated antibiotic resistance, which occasionally occurs, is another matter because of the possibility of the resistance spreading to other, more harmful species and genera. The transmissible enterococcal resistance against glycopeptide antibiotics (vancomycin and teicoplanin) is particularly noteworthy, as vancomycin is one of the last effective antibiotics left in the treatment of certain multidrug-resistant pathogens. New species and more specific strains of probiotic bacteria are constantly identified. Prior to incorporating new strains into products their efficacy should be carefully assessed, and a case by case evaluation as to whether they share the safety status of traditional food-grade organisms should be made. The current documentation of adverse effects in the literature is reviewed. Future recommendations for the safety of already existing and new probiotics will be given.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0168-1605(98)00128-7

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 83 references

Cited by

See all 898

Metadata

Authors
Salminen, S.
Affiliations
University of Turku (FI)
Corresponding author
Salminen, S
Venue
International Journal of Food Microbiology
Publisher
Elsevier BV
Published
1998-10-20
Volume
44
Issue
1-2
Pages
93-106
ISSN
0168-1605 (ISSN-L)
OpenAlex
W2105634693
Cited by
884
References
83
Citations by year
2026: 10 · 2025: 20 · 2024: 26 · 2023: 27 · 2022: 27 · 2021: 30 · 2020: 32 · 2019: 33 · 2018: 27 · 2017: 24 · 2016: 32 · 2015: 44 · 2014: 59 · 2013: 40 · 2012: 55
FWCI
35.18
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • International Journal of Food Microbiology (publishedVersion)
  • PubMed (publishedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
probiotics, probiotic safety, lactic acid bacteria, GRAS, antibiotic resistance, plasmid-mediated resistance, vancomycin resistance, Enterococcus, Lactobacillus, Lactococcus, Streptococcus, fermented dairy products, adverse effects, risk-benefit assessment
MeSH terms
Animals, Clinical Trials as Topic, Drug Resistance, Microbial, Humans, Lactobacillus, Plasmids, Vancomycin, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Demonstration of safety of probiotics—A review. https://app.cochat.ai/papers/10.1016/s0168-1605(98)00128-7
The paper
Salminen, S. (1998). Demonstration of safety of probiotics—A review. International Journal of Food Microbiology. https://doi.org/10.1016/s0168-1605(98)00128-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.